¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"limiting viscosity number"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • kinematic viscosity
    ¿îµ¿ÇÐÀûÁ¡¼ºµµ
  • viscosity
    Á¡µµ, Á¡¼ºµµ
  • glial limiting membrane
    ¾Æ±³°æ°è¸·, ±³¼¼Æ÷°æ°è¸·
  • gradient limiting reabsorption
    ³óµµ°æ»çÁ¦ÇÑÀçÈí¼ö
  • limiting concentration
    ÇѰè³óµµ
  • limiting dilution method
    ÇѰèÈñ¼®¹ý
  • limiting membrane
    °æ°è¸·
  • rate limiting enzyme
    ¼ÓµµÁ¦ÇÑÈ¿¼Ò
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ
  • self-limiting
    ÀÚ±âÇÑÁ¤-
  • attributable number
    ±â¿©¼ö
  • Avogadro¡¯s number
    ¾Æº¸°¡µå·Î¼ö
  • acquisition matrix number
    ȹµæÇà·Ä¼ö
  • basic number
    ±âº»¼ö
  • copy number
    º¹Á¦¼ö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • viscosity
    Á¡¼º
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò
  • self-limiting
    ÀÚ±âÁ¦ÇÑ
  • number
    ¼ö
  • basic number
    ±âº»¼ö
  • rational number
    À¯¸®¼ö
  • real number
    ½Ç¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apparent viscosity
    °Ñº¸±âÁ¡¼º
  • kinematic viscosity
    µ¿Á¡µµ, ¿îµ¿ÇÐÀûÁ¡¼º
  • viscosity
    Á¡¼º
  • adjustable pressure limiting valve
    ¾Ð·ÂÁ¦ÇÑÁ¶ÀýÆÇ¸·
  • limiting concentration
    ÇѰè³óµµ
  • limiting dilution culture
    ÇѰèÈñ¼®¹è¾ç¹ý, ´ÜÀϼ¼Æ÷¹è¾ç¹ý
  • limiting dilution
    Á¦ÇÑÈñ¼®
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò
  • glial limiting membrane
    ¾Æ±³°æ°è¸·
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ÇÑÀçÈí¼ö
  • limiting line
    ÇѰ輱
  • limiting membrane
    °æ°è¸·
  • limiting dilution method
    ÇѰèÈñ¼®¹ý
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ
  • acquisition matrix number
    ȹµæÇà·Ä¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apparent viscosity
    °Ñº¸±â Á¡¼º(µµ) (¡­ïÄàõöô).
  • pulmonary viscosity
    ÆóÁ¡¼º(øËïÄàõ).
  • relative viscosity
    »ó´ëÁ¡µµ(ßÓÓßïÄöô).
  • adjustable pressure limiting valve
    Á¶ÀýÇü ¾Ð·ÂÁ¦ÇÑ ¹ëºê.
  • anterior limiting membrane
    ¾Õ°æ°èÆÇ
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
  • inner limiting membrane
    ³»°æ°è¸·.
  • inner limiting membrane
    ¼Ó°æ°èÃþ
  • inner limiting membrane
    ³»°æ°è¸·, ¼Ó°æ°èÃþ.
  • posterior limiting membrane
    µÚ°æ°èÆÇ
  • pressure limiting valve
    ¾Ð·ÂÁ¦Çѹëºê.
  • rate limiting
    ¼ÓµµÁ¦ÇÑÀÇ.
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò(áÜöôðàï½ý£áÈ).
  • rate limiting reaction
    ¼ÓµµÁ¦ÇѹÝÀÀ.
  • Haploid number
    ´Ü¹èü(Ó¤ÛÃô÷)ÀÇ ¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apparent viscosity
    °Ñº¸±â Á¡¼º(µµ) (¡­ïÄàõöô).
  • blood viscosity
    Ç÷¾×Á¡ (¼º)µµ.
  • blood viscosity
    Ç÷¾×Á¡(¼º)µµ(úìäûïÃà÷Óø).
  • fluid viscosity
    ¾×üÁ¡µµ
  • kinematic viscosity
    µ¿Á¡µµ(ÔÑïÄöô).
  • melt viscosity
    À¶ÇØÁ¡µµ(¡­ïÄöô).
  • pulmonary viscosity
    ÆóÁ¡¼º(øËïÄàõ).
  • relative viscosity
    »ó´ëÁ¡µµ(ßÓÓßïÄöô).
  • serum viscosity
    Ç÷ûÁ¡µµ, Ç÷ûÁ¡¼º
  • viscosity
    Á¡¼º (ïÄàõ)
  • viscosity
    Á¡¼º(ïÄàõ), Á¡µµ(ïÄöô), Á¡Âø¼º
  • viscosity
    Á¡¼º
  • viscosity
    Á¡¼º(ïÄàõ), Á¡µµ(ïÄöô), Á¡Âø¼º.
  • viscosity formula
    Á¡Á¶µµ°è»ê½Ä.
  • volume viscosity
    üÀûÁ¡¼º·ü(¡­ïÄàõëÒ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Limiting plate
    °£¼Ò¿±°æ°èÆÇ
    [¿¾ ¿ë¾î] °£¼Ò¿±°æ°èÆÇ
  • Limiting membrane
    °æ°è¸·
    [¿¾ ¿ë¾î] °æ°è¸·
  • Periventricular glial limiting membrane
    ³ú½ÇÁÖÀ§¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] ³ú½ÇÁÖÀ§°æ°è¸·
  • Posterior limiting membrane
    µÚ°æ°èÆÇ
    [¿¾ ¿ë¾î] Èİæ°èÆÇ
  • Outer limiting membrane
    ¹Ù±ù°æ°èÃþ
    [¿¾ ¿ë¾î] ¿Ü°æ°èÃþ
  • External glial limiting membrane
    ¹Ù±ù¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] ¿Ü±³°æ°è¸·
  • Inner limiting membrane
    ¼Ó°æ°èÃþ
    [¿¾ ¿ë¾î] ³»°æ°èÃþ
  • Internal glial limiting membrane
    ¼Ó¾Æ±³¼¼Æ÷°æ°è¸·
    [¿¾ ¿ë¾î] ³»±³°æ°è¸·
  • Anterior limiting membrane
    ¾Õ°æ°èÆÇ
    [¿¾ ¿ë¾î] Àü°æ°èÆÇ
  • Superficial glial limiting membrane
    Ç¥¸é¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] õ±³°æ°è¸·
  • Perivascular glial limiting membrane
    Ç÷°üÁÖÀ§¾Æ±³°æ°è¸·
    [¿¾ ¿ë¾î] Ç÷°üÁÖÀ§°æ°è¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • limiting viscosity number
    Á¦ÇÑÁ¡µµ¼ö(ð¤ùÚïÄÓøâ¦)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • viscosity number
    Á¡µµ¼ö(ïÄÓøâ¦)
  • rate-limiting step
    ¼ÓµµÁ¦ÇÑ ´Ü°è(áÜÓøð¤ùÚÓ«Í­)
  • limiting amino acid
    Á¦ÇÑ(ð¤ùÚ)¾Æ¹Ì³ë»ê(ß«)
  • limiting current
    ÇѰèÀü·ù(ùÚÍ£ï³×µ)
  • limiting reagent
    Á¦Çѽþà(ð¤ùÚãËå·)
  • limiting velocity
    Á¦ÇѼӵµ(ð¤ùÚáÜÓø)
  • van't Hoff limiting law
    ¹ÝÆ® È£ÇÁ Á¦ÇÑ ¹ýÄ¢(ð¤ùÚÛööÎ)
  • coefficient of viscosity
    Á¡µµ°è¼ö(ïÄÓøÌõâ¦)
  • dynamic viscosity
    µ¿Àû Á¡µµ(ÔÑîÜïÇÓø)
  • intrinsic viscosity
    °íÀ¯ Á¡µµ(ͳêóïÄÓø)
  • kinematic viscosity
    µ¿Á¡µµ(ÔÑïÄÓø)
  • reduced viscosity
    ȯ»ê Á¡µµ(üµß©ïÄÓø)
  • relative viscosity
    »ó´ë Á¡µµ(ßÓÓßïÄÓø)
  • specific viscosity
    ºñÁ¡µµ(ÝïïÄÓø)
  • viscosity
    "Á¡¼º(ïÄàõ), Á¡µµ(ïÄÓø)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • viscosity
    Á¡¼º, Á¡µµ, Á¡Âø¼º
  • acquisition matrix number
    ȹµæÇà·Ä¼ö, ȹµæ¸ÅÆ®¸¯½º¼ö
  • atomic number
    ¿øÀÚ¹øÈ£
  • Hounsfield number
    ÇϿÇʵå¼öÄ¡
  • mass number
    Áú·®¼ö
  • matrix number
    Çà·Ä¼ö
  • number
    ¼ö, ¹øÈ£
  • number of acquisition
    ȹµæÈ¸¼ö
  • number of excitations [=NEX]
    ¿©±âȸ¼ö
  • number of signal average [=NSA]
    ½ÅÈ£Æò±Õȸ¼ö
  • odd number
    Ȧ¼ö, ±â¼ö
  • quantum number
    ¾çÀÚ¼ö
  • Reynold's number
    ·¹À̳îµå¼ö
  • spin quantum number
    ½ºÇɱ¤ÀÚ¼ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
VNTR variable number of tandem repeats; variable copy number tandem repeats
ELM external limiting membrane; extravascular lung mass
FLS fatty liver syndrome; Fellow of the Linnean Society; fibrous long-spacing [collagen]; flow-limiting ...
ILM insulin-like material; internal limiting membrane
LIC left internal carotid [artery]; limiting isorrheic concentration; local intravascular coagulation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PV Plasma viscosity
WBV Whole Blood Viscosity
DLT Dose limiting toxicities
DLT Dose limiting toxicity
DLTs Dose-limiting toxicities
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • melt viscosity
    À¶ÇØ Á¡µµ
  • relative viscosity
    »ó´ë Á¡µµ
  • synovial fluid viscosity
    Ȱ¾× Á¡Á¶µµ
  • viscosity
    Á¡¼º, Á¡µµ, Á¡Âø¼º
    1. Àü´Ü·Â¿¡ ´ëÇØ ³»ºÎÀÇ ÀúÇ×À» °áÁ¤ÇÏ´Â À¯Ã¼ÀÇ ¹°¸®Àû ¼ºÁú. 2. ±¸¼º ºÐÀÚ°¡ ¼­·Î ¹Ì²ô·¯Áú ¶§¿Í °°ÀÌ ¸¶Âû¿¡ ÀÇÁ¸ÇÏ´Â ¹°ÁúÀÇ ¹°¸®Àû ¼ºÁú. ÀϹÝÀûÀ¸·Î ºÐÀÚ ÀÀÁý·ÂÀÇ °á°ú·Î¼­ ¹°ÁúÀÌ À¯µ¿°ú ÇüÅ º¯È­¿¡ ÀûÀÀÇÏ´Â °Í.
  • limiting condition
    Á¦ÇÑ ¿äÀÎ
  • limiting factor
    ÇѰè ÀÎÀÚ, Á¦ÇÑ ÀÎÀÚ, ÇÑÁ¤ ÀÎÀÚ
  • periventricular glial limiting membrane
    ³ú½Ç ÁÖÀ§ ¾Æ±³ °æ°è¸·
  • rate-limiting enzyme
    ¼Óµµ Á¶Àý È¿¼Ò
  • self-limiting
    ÀÚ±â ÇÑÁ¤¼º, ÀÚ±â ÇÑÁ¤Àû
    ¿ÜºÎÀÇ ¿µÇâ¿¡ ÀÇÇØ¼­°¡ ¾Æ´Ï¶ó, ÀÚ±â ÀÚ½ÅÀÇ Æ¯¼º¿¡ ÀÇÇØ¼­ ÇÑÁ¤µÈ, ÀÏÁ¤ÇÏ°Ô ÇÑÁ¤µÈ °æ°ú¸¦ ÃëÇÏ´Â Áúȯ¿¡ ´ëÇØ¼­ ¸»ÇÑ´Ù.
  • absolute number
    Àý´ë ¼ö, ¹«¸í ¼ö
  • acquisition matrix number
    ȹµæ Çà·Ä¼ö, ȹµæ ¸ÅÆ®¸¯½º ¼ö
  • half the number
    ¹Ý¼ö
  • isotopic number
    µ¿À§ ¿ø¼Ò ¹øÈ£
  • most probable number
    ÃÖÀû È®¼ö, ÃÖÈ®¼ö
    ¼öÁúÀÇ ´ëÀå±Õ ¿À¿°µµ.
  • number of acquisition
    ȹµæ ȸ¼ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absolute viscosity Force per unit area applied tangentially to a fluid, causing unit rate of displacement of parallel planes separated by a unit distance; units in CGS system: poise.
(05 Mar 2000)
anomalous viscosity The viscous behaviour of nonhomogenous fluids or suspensions, e.g., blood, in which the apparent viscosity increases as flow or shear rate decreases toward zero.
(05 Mar 2000)
apparent viscosity <physiology> This refers to the ratio of shear stress to shear rate in a fluid, this ratio is dependent on the rate of shear.
(09 Oct 1997)
blood viscosity The internal resistance of the blood to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as sickle cell anaemia and polycythemia.
(12 Dec 1998)
magnetic viscosity <physics> A magnetic field in a conducting fluid will damp fluid motions perpendicular to the field lines, similar to ordinary viscosity, even in the absence of sizeable mechanical forces or electric fields.
(09 Oct 1997)
relative viscosity The ratio of the viscosity of a solution or dispersion to the viscosity of the solvent or continuous phase.
(05 Mar 2000)
viscosity <chemistry> A physical property of fluids that determines the internal resistance to shear forces.
(18 Nov 1997)
coefficient of viscosity The value of the force per unit area required to maintain a unit relative velocity between two parallel planes a unit distance apart.
(05 Mar 2000)
Poiseuille's viscosity coefficient An expression of the viscosity as determined by the capillary tube method; the coefficient &eta; = (&pi;Pr4t/8vl), where P is the pressure difference between the inlet and outlet of the tube, r the radius of the tube, l its length, and v the volume of liquid delivered in the time t. If volume is in cm3, time is in seconds, and l and r are in cm, then n will be in poise.
(05 Mar 2000)
newtonian viscosity The viscosity characteristics of a newtonian fluid.
(05 Mar 2000)
dynamic viscosity The internal or molecular frictional resistance of a fluid by Newton's law of viscosity as the ratio of the applied force per unit area to the relative velocity of adjacent fluid layers (produced by the force).
(05 Mar 2000)
kinematic viscosity A measure used in studies of fluid flow; the dynamic viscosity, u, in poises divided by the density of the material; units: stokes.
(05 Mar 2000)
Abbe's law of limiting resolution <physics> For a periodic structure of units separated by distance d and obliquely illuminated by the unrefracted ray and one of the two diffracted rays (extremely oblique illumination).
Abbe applied the law of diffraction: d = 0.5 lambda /NA, where: lambda = wavelength of the monochromic light or shortest of mixed wavelengths NA = the limiting numerical aperture (NA) of objective or condenser.
(05 Aug 1998)
anterior limiting layer of cornea A transparent homogeneous acellular layer, 6 to 9 um thick, lying between the basal lamina of the outer layer of stratified epithelium and the substantia propria of the cornea; considered to be a basement membrane.
Synonym: lamina limitans anterior corneae, anterior elastic layer, Bowman's membrane, lamina elastica anterior, limiting layers of cornea.
(05 Mar 2000)
anterior limiting ring The periphery of the cornea marking the termination of Descemet's membrane and the anterior border of the trabecular meshwork; an important landmark in gonioscopy.
Synonym: Schwalbe's ring.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • limiting
    Á¦ÇÑÇÏ´Â;Á¦ÇÑÀû Çü¿ë»ç(¸í»ç¸¦ ÇÑÁ¤ÇÏ´À ±¸½Ç»ÓÀÎ this,some,certain µî)
  • viscosity
    Á¡Áú
  • viscosity
    Á¡Âø¼º;Á¡Áú;Á¡µµ
  • any number of
    ²Ï ¸¹Àº
  • number
    ¼ö,¹øÈ£,¼¼´Ù,¹øÈ£¸¦ ¸Å±â´Ù
  • International Standard Book Number
    ±¹Á¦ Ç¥ÁØ µµ¼­¹øÈ£(ISBN)
  • International Standard Serial Number
    (¹Ì)±¹Á¦ Ç¥ÁØ °£Ç๰ÀϷùøÈ£
  • Mach number
    ¸¶Çϼö
  • accession number
    µµ¼­¼ö³³¹øÈ£
  • atomic number
    ¿øÀÚ ¹øÈ£
  • atonic number
    ¿øÀÚ¹øÈ£
  • back number
    µÚÀÇ
  • back number
    µÚÀÇ
  • call number
    µµ¼­Á¤¸®(û±¸)¹øÈ£
  • cardinal number(numeral)
    񃬔
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á